Focused SOAP Note and Patient Case Presentation, Part 2

Subjective:

CC (chief complaint): “I am having more trouble remembering things lately,” reported by the caregiver (wife), as the patient has difficulty articulating symptoms.

HPI: J.D. is a 79-year-old Caucasian male diagnosed with mild neurocognitive illness, presumably Alzheimer’s, attending a follow-up appointment due to progressive cognitive deterioration over the past four months. According to his wife, he has exhibited escalating confusion, particularly in the late afternoon, aligning with sundowning behavior. He consistently poses identical inquiries, misplaces ordinary items, and has demonstrated a deterioration in handling fundamental financial matters. On two instances, he exhibited disorientation in familiar areas within the house. Although he is predominantly cooperative, his sleep has been interrupted by nocturnal awakenings and excessive diurnal dozing. He possesses no antecedents of hallucinations, delusions, or aggressiveness. No evidence of acute distress or suicidal ideation is seen. His appetite remains consistent. His wife refutes any recent falls or substantial behavioral changes but observes that his short-term memory has deteriorated markedly compared to six months prior. His functional capacity is deteriorating.

Substance Current Use: The patient disputes any consumption of tobacco or illegal substances. No present alcohol consumption; previously consumed wine just on exceptional occasions. No reliance on coffee, nor any history of substance use disorder or withdrawal symptoms.

Medical History: Benign prostatic hyperplasia, type 2 diabetes mellitus, moderate neurocognitive disorder (likely Alzheimer’s), osteoarthritis with sporadic joint pain, hypertension, and hyperlipidemia.

  • Current Medications:
    • Donepezil 10 mg orally once daily—used for 2 years for mild neurocognitive dysfunction (Alzheimer’s disease).
    • Metformin 500 mg orally twice a day—used for 8 years for type 2 diabetes mellitus.
    • Lisinopril 10 mg orally once daily—used for 10 years to control hypertension.
    • Atorvastatin 20 mg orally at bedtime—administered for 7 years for hyperlipidemia.
    • Tamsulosin 0.4 mg orally once a day is used for five years for benign prostatic hyperplasia (BPH).
    • Acetaminophen 500 mg orally as needed—infrequent use for joint discomfort associated with osteoarthritis (over-the-counter).
  • Allergies: None
  • Reproductive Hx: heterosexual male. He is not currently involved in any sexual activity. There are no documented instances of prior erectile dysfunction. There are no problems with desire or sexual performance. He is married and maintains a monogamous relationship with his spouse. No STD/STIs/HIV/AIDs

ROS:

  • GENERAL: Denies pyrexia, lethargy, or involuntary weight reduction.
  • HEENT: denies pharyngitis, headache, visual abnormalities, hearing impairment, or nasal blockage.
  • SKIN: denies the existence of itching, rashes, or sores.
  • CARDIOVASCULAR: Denies feeling edema, palpitations, or chest pain.
  • RESPIRATORY: No complaints of dyspnea, wheezing, or coughing were made.
  • GASTROINTESTINAL: Denies any discomfort in the abdomen, nausea, vomiting, diarrhea, or constipation. It is said that appetite is stable.
  • GENITOURINARY: Denies urine incontinence, hematuria, or dysuria. The patient displays stable urinary function while taking Tamsulosin.
  • NEUROLOGICAL: Denies headache, syncope, vertigo, paresthesia, or tremors. The patient displays a gradual deterioration in memory and a slight disorientation.
  • MUSCULOSKELETAL: Refutes joint edema or muscular debility. The patient experiences intermittent stiffness.
  • HEMATOLOGIC: Denies atypical bruises or hemorrhaging.
  • LYMPHATICS: No reported enlarged glands or history of lymphadenopathy.
  • ENDOCRINOLOGICAL: Denies polyuria, polydipsia, and heat or cold intolerance. It has been found that glucose levels are well controlled.

Objective:

Vital Signs: BP: 132/78 mmHg, HR: 74 bpm, regular, RR: 16 breaths/min, T: 97.8°F (36.6°C), Oxygen Saturation: 98% in ambient air. Ht: 5 feet 9 inches (175 centimeters), Wt: 172 pounds (78 kilograms), BMI: 25.5

Physical Exam:

  • General: The patient exhibits claimed age and is cooperative, although muddled regarding date and time.
  • HEENT: Normocephalic, atraumatic, PERRLA; no focal impairments seen.
  • Cardiac: S1 and S2 are standard; no gallops, rubs, or murmurs were heard.
  • Pulmonary: Auscultation reveals clear lung fields bilaterally, with no rales or wheezes present.
  • Gastrointestinal: soft abdomen, non-tender, with no palpable tumors or organomegaly.
  • Neurological: Alert but oriented solely to person and location. Impaired short-term memory. Ambulation is stable, devoid of tremors. Cranial nerves II through XII are largely intact.
  • Psych: The affect is appropriate, but it appears flat at times. Insight and judgment are impaired.

 

Diagnostic Results:

  • MMSE: 22/30 (previously 25/30 six months ago), indicating a decline in cognitive function.
  • Clock Drawing Test: Impaired.
  • Recent Labs: A1C: 6.8%, LDL: 78 mg/dL, BUN/Cr WNL (within normal limits).

Assessment:

Mental Status Examination: Mr. J.D. is a 79-year-old Caucasian male who presents as his stated age. He is slightly untidy yet suitably attired for the weather conditions. He demonstrates cooperation with the examiner; however, he sometimes necessitates redirection. No indication of aberrant movements or psychomotor agitation is present. His speech is articulate, with an appropriate volume and tone, if somewhat deliberate. Cognitive processes are typically goal-oriented but may occasionally deviate due to challenges in retrieving recent information. He refutes the presence of auditory or visual hallucinations and displays no signs of delusional thought processes. His wife characterizes his mood as “fine,” and his affect is muted yet appropriate. He refutes any thoughts of suicide or homicide. He is awake yet oriented solely to person and location. Cognitive function is compromised, especially in short-term memory. He could not remember three items after five minutes. Judgment is compromised, and insight is restricted, as he is oblivious to the severity of his memory deterioration.

Diagnostic Impression:

  1. J.D. has Major Neurocognitive Disorder, probably Alzheimer’s, which means he has significant problems with memory, thinking skills, and understanding his surroundings, making it hard for him to take care of himself in daily life (Jones, 2021). His MMSE has decreased from 25 to 22, and he exhibits impaired judgment, disorientation, sundowning, and deficient short-term memory. He necessitates caregiver support and exhibits diminished insight.
  2. Delirium: Delirium is ruled out according to DSM-5-TR criteria due to the lack of abrupt onset and variable course (Fong & Inouye, 2022). Mr. J.D.’s symptoms have gradually worsened over several months, with no indications of acute medical conditions, infections, or drunkenness. During assessment, he often maintains his focus, a skill that delirium would significantly undermine.
  3. Depression (Major Depressive Disorder with cognitive features): Despite the caregiver observing some mood lability, Mr. J.D. refutes the presence of enduring poor mood, anhedonia, hopelessness, or suicidal ideation. The fundamental characteristics of major depression are absent, as per DSM-5-TR (Hammar et al., 2022). His cognitive deficiencies are primary and progressive, indicating neurocognitive decline rather than depression-induced cognitive impairment, as they are neither episodic nor mood-congruent.

Reflections: This particular case of Mr. J.D. underscores the intricate difficulties in addressing gradual cognitive deterioration in elderly individuals. It is necessary to think about autonomy while prioritizing safety, particularly in the contexts of driving and medication administration. Legal matters, including the establishment of a power of attorney and the initiation of advanced care planning, must be addressed with sensitivity to maintain dignity while safeguarding the patient’s interests (Jones, 2021). The social determinants of health, such as Mr. J.D.’s age, retirement status, and reliance on his wife, affect access to healthcare and support networks. While his financial stability seems sufficient, impending requirements may exert pressure on resources. His medical history of hyperlipidemia, type 2 diabetes, and hypertension elevates his risk for vascular-related cognitive impairment, necessitating continuous monitoring and preventive measures (Bermejo‐Pareja et al., 2020). Health promotion must prioritize caregiver assistance, cognitive stimulation, home safety, and the management of comorbidities. It is essential to honor cultural norms on aging and dementia during educational and care planning dialogues with the family.

Case Formulation and Treatment Plan:

  • Diagnostic Studies Ordered: RPR, vitamin B12, folate, thyroid-stimulating hormone, CBC, CMP, and non-contrast magnetic resonance imaging of the brain to exclude reversible etiologies of cognitive deterioration and assess structural alterations in the brain (Jones, 2021).
  • Referrals: Neurology for additional cognitive assessment and subsequent MRI review; occupational therapy for home safety assessment; Alzheimer’s support group and adult day care services (Maldonado & Sher, 2024).
  • Psychopharmacology: Starting memantine 5 mg orally once daily, escalating to 10 mg twice daily over four weeks, alongside donepezil 10 mg orally once daily (Bermejo‐Pareja et al., 2020).
  • Medication Education: Patients were educated about the risks and advantages of Memantine, which include dizziness, headache, and constipation. The advice was to refrain from making abrupt stops. The patient was directed to document negative consequences.
  • Substance Use: It is recommended to stay away from alcohol and over-the-counter or herbal medications without prior consultation due to potential pharmacological interactions (Botero-Rodríguez et al., 2021).
  • Disposition: The patient continues to reside at home with a caregiver.
  • Emergency Planning: The patient was provided crisis contact numbers and emergency protocols.
  • Patient Education: The caregiver was educated on disease development, safety measures, routine reinforcement, and financial/legal planning.
  • Follow-Up: Reevaluate in one month for drug efficacy and MMSE; laboratory tests in three months. Medical intervention is essential to decelerate development and improve safety and functionality.

References

Bermejo‐Pareja, F., Contador, I., Del Ser, T., Olazarán, J., Llamas‐Velasco, S., Vega, S., & Benito‐León, J. (2020). Predementia constructs: Mild cognitive impairment or mild neurocognitive disorder? A narrative review. International Journal of Geriatric Psychiatry, 36(5), 743–755. https://doi.org/10.1002/gps.5474

Botero-Rodríguez, F., Sastoque, A. M. C., Escudero, J. M. S., & Santamaría-García, H. (2021). Neuropsychiatric symptoms in patients with neurocognitive disorders and their performance are compared between mild and major stages. Journal of Alzheimer’s Disease, 85(4), 1735–1744. https://doi.org/10.3233/jad-215283

Fong, T. G., & Inouye, S. K. (2022). The interrelationship between delirium and dementia: the importance of delirium prevention. Nature Reviews Neurology, 18(10), 579–596. https://doi.org/10.1038/s41582-022-00698-7

Hammar, Å., Ronold, E. H., & Rekkedal, G. Å. (2022). Cognitive Impairment and Neurocognitive Profiles in Major Depression—A Clinical Perspective. Frontiers in Psychiatry, 13. https://doi.org/10.3389/fpsyt.2022.764374

Jones, K. C. (2021). Update on major neurocognitive disorders. FOCUS the Journal of Lifelong Learning in Psychiatry, 19(3), 271–281. https://doi.org/10.1176/appi.focus.20210004

Maldonado, J. R., & Sher, Y. (2024). Neurocognitive disorders. In Springer eBooks (pp. 3111–3169). https://doi.org/10.1007/978-3-030-51366-5_81

CLICK HERE TO ORDER A PLAGIARISM-FREE PAPER

Topic: Neurocognitive Disorder

sychiatric notes are a way to reflect on your practicum experiences and connect the experiences to the learning you gain from your weekly Learning Resources. Focused SOAP notes, such as the ones required in this practicum course, are often used in clinical settings to document patient care.

For this Assignment, you will document information about a patient that you examined during the last 4 weeks, using the Focused SOAP Note Template provided. You will then use this note to develop and record a case presentation for this patient.

Published by
superadmin
View all posts